Evaluation of the intestinal environment for pregnant women and infants
- Conditions
- atopic dermatitis chilrdren
- Registration Number
- JPRN-UMIN000043097
- Lead Sponsor
- Metabologenomics, Inc.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Not provided
(1) Users of topical steroids that are classified as "very strong (group II)" or stronger in "Guidelines for the Treatment of Atopic Dermatitis 2018" by the Japanese Dermatological Association. (2) Subjects who have consumed medicines which affect the intestinal environment within the last 1 month to the observation observation start. (3) Subjects who have current medical history/anamnesis of severe cardiac, hepatic, renal or digestive diseases. (4) Subjects who are currently participating, or who have participated in other study for medicine of food within the last 4 weeks of the present study, or who possibly participate in another clinical trial after agreement of this study. (5) Subjects who have been determined ineligible by principal investigator or sub-investigator.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method